                         SEQUENCE LISTING

<110>  The Regents of the University of California
       Madonna, Michael
       Benoit, Stephen
       Millhauser, Glenn
 
<120>  Appetite Stimulating Protein

<130>  SC2011_318_PCT

<150>  US 61/504,370
<151>  2011-07-05

<160>  14    

<170>  PatentIn version 3.5

<210>  1
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AgRP(83-120): peptide designed as a truncation of human
       Agouti-Related Protein.

<400>  1

Ser Ser Arg Arg Cys Val Arg Leu His Glu Ser Cys Leu Gly Gln Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Pro Ala Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Ala Phe Cys Tyr Cys Arg 
        35              


<210>  2
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AgRP(87-132): peptide designed as a truncation of human 
       Agouti-Related Protein.

<400>  2

Cys Val Arg Leu His Glu Ser Cys Leu Gly Gln Gln Val Pro Cys Cys 
1               5                   10                  15      


Asp Pro Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn Ala Phe Cys Tyr 
            20                  25                  30          


Cys Arg Lys Leu Gly Thr Ala Met Asn Pro Cys Ser Arg Thr 
        35                  40                  45      


<210>  3
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AgRP(87-120): peptide designed as a truncation of Human 
       Agouti-Related Protein.

<400>  3

Cys Val Arg Leu His Glu Ser Cys Leu Gly Gln Gln Val Pro Cys Cys 
1               5                   10                  15      


Asp Pro Ala Ala Thr Cys Tyr Cys Arg Phe Phe Asn Ala Phe Cys Tyr 
            20                  25                  30          


Cys Arg 
        


<210>  4
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AgRP-2Q: peptide designed to eliminate positive charges from 
       AgRP(83-132).

<400>  4

Ser Ser Arg Arg Cys Val Arg Leu His Glu Ser Cys Leu Gly Gln Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Pro Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Ala Phe Cys Tyr Cys Arg Gln Leu Gly Thr Ala Met Asn Pro Cys Ser 
        35                  40                  45              


Gln Thr 
    50  


<210>  5
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AgRP-4Q: peptide designed to eliminate positive charges from 
       AgRP(83-132).

<400>  5

Ser Ser Gln Gln Cys Val Arg Leu His Glu Ser Cys Leu Gly Gln Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Pro Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Ala Phe Cys Tyr Cys Arg Gln Leu Gly Thr Ala Met Asn Pro Cys Ser 
        35                  40                  45              


Gln Thr 
    50  


<210>  6
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AgRP-2K: peptide designed with additional Lysine residues in 
       AgRP(83-132).

<400>  6

Ser Ser Arg Arg Cys Val Arg Leu His Glu Ser Cys Leu Gly Gln Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Pro Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Ala Phe Cys Tyr Cys Arg Lys Leu Lys Thr Lys Met Asn Pro Cys Ser 
        35                  40                  45              


Arg Thr 
    50  


<210>  7
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AgRP-4K: peptide designed with additional Lysine residues in 
       AgRP(83-132).

<400>  7

Lys Lys Arg Arg Cys Val Arg Leu His Glu Ser Cys Leu Gly Gln Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Pro Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Ala Phe Cys Tyr Cys Arg Lys Leu Lys Thr Lys Met Asn Pro Cys Ser 
        35                  40                  45              


Arg Thr 
    50  


<210>  8
<211>  50
<212>  PRT
<213>  Homo sapiens

<400>  8

Ser Ser Arg Arg Cys Val Arg Leu His Glu Ser Cys Leu Gly Gln Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Pro Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Ala Phe Cys Tyr Cys Arg Lys Leu Gly Thr Ala Met Asn Pro Cys Ser 
        35                  40                  45              


Arg Thr 
    50  


<210>  9
<211>  50
<212>  PRT
<213>  Bos taurus

<400>  9

Ser Pro Arg Arg Cys Val Arg Leu His Glu Ser Cys Leu Gly His Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Pro Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Ala Phe Cys Tyr Cys Arg Lys Leu Gly Thr Thr Thr Asn Pro Cys Ser 
        35                  40                  45              


Arg Thr 
    50  


<210>  10
<211>  50
<212>  PRT
<213>  Mus musculus

<400>  10

Ser Pro Arg Arg Cys Val Arg Leu His Glu Ser Cys Leu Gly Gln Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Pro Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Ala Phe Cys Tyr Cys Arg Lys Leu Gly Thr Ala Thr Asn Leu Cys Ser 
        35                  40                  45              


Arg Thr 
    50  


<210>  11
<211>  51
<212>  PRT
<213>  Rattus norvegicus

<400>  11

Ser Pro Arg Arg Cys Val Arg Leu His Glu Ser Cys Leu Gly Gln Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Leu Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Thr Phe Cys Tyr Cys Arg Lys Leu Gly Thr Gly Thr Thr Asn Leu Cys 
        35                  40                  45              


Ser Arg Pro 
    50      


<210>  12
<211>  50
<212>  PRT
<213>  Sus scrofa

<400>  12

Ser Pro Arg Arg Cys Val Arg Leu His Glu Ser Cys Leu Gly His Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Pro Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Ala Phe Cys Tyr Cys Arg Lys Leu Gly Thr Ala Thr Asn Pro Cys Ser 
        35                  40                  45              


Arg Thr 
    50  


<210>  13
<211>  44
<212>  PRT
<213>  Ovis aries

<400>  13

Ser Pro Arg Arg Cys Val Arg Leu His Glu Ser Cys Leu Gly His Gln 
1               5                   10                  15      


Val Pro Cys Cys Asp Pro Cys Ala Thr Cys Tyr Cys Arg Phe Phe Asn 
            20                  25                  30          


Ala Phe Cys Tyr Cys Arg Lys Leu Gly Thr Thr Thr 
        35                  40                  


<210>  14
<211>  4
<212>  PRT
<213>  Homo sapiens

<400>  14

Arg Glu Pro Arg 
1               


